GB Patent

GB2090529A — Thrombosis-prophylactic and curing agent

Assigned to NOF Corp · Expires 1982-07-14 · 44y expired

What this patent protects

A thrombosis-preventing and curing agent containing at least one member selected from among (all-Z)-4, 7, 10, 13, 16, 19-docosahexanoic acid, pharmaceutically acceptable salt, ester and amide thereof as effective ingredient. This agent is absorbed through the intestine so well th…

USPTO Abstract

A thrombosis-preventing and curing agent containing at least one member selected from among (all-Z)-4, 7, 10, 13, 16, 19-docosahexanoic acid, pharmaceutically acceptable salt, ester and amide thereof as effective ingredient. This agent is absorbed through the intestine so well that it can be used internally, is stable in blood and shows excellent effect of preventing blood platelets from agglutinizing.

Drugs covered by this patent

Patent Metadata

Patent number
GB2090529A
Jurisdiction
GB
Classification
—
Expires
1982-07-14
Drug substance claim
No
Drug product claim
No
Assignee
NOF Corp
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.